Nuciferine Inhibits TMEM16A in Dietary Adjuvant Therapy for Lung Cancer

Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety and painlessness. Developing new functional food and exploring novel drug targets is important for lung cancer adjuvant therapy. This study c...

Full description

Saved in:
Bibliographic Details
Published inJournal of agricultural and food chemistry Vol. 70; no. 12; pp. 3687 - 3696
Main Authors Bai, Xue, Liu, Xinyi, Li, Shuting, An, Hailong, Kang, Xianjiang, Guo, Shuai
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 30.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety and painlessness. Developing new functional food and exploring novel drug targets is important for lung cancer adjuvant therapy. This study confirmed that the active ingredient nuciferine of the lotus leaf was a novel TMEM16A inhibitor by whole-cell patch clamp experiments and site-directed mutagenesis experiments. CCK8 assay, colony formation assay, wound healing assay, and Annexin-V assay were combined to prove that nuciferine inhibited the proliferation and migration of lung cancer cells and promoted cancer cell apoptosis by targeting TMEM16A. Moreover, the combination of nuciferine and cisplatin significantly enhanced the anti-cancer effect of cisplatin. In addition, the signal transduction pathway of nuciferine regulating LA795 cell proliferation, migration, and apoptosis was confirmed by western blot experiments. In vivo experiments showed that nuciferine was a safe and effective natural anti-cancer product for lung cancer. Tissue section pathological detection and pharmacokinetic experiments verified that intragastric administration of nuciferine significantly enhanced the cancer therapy effect of cisplatin and counteracted the toxicity of high concentrations of cisplatin. Therefore, nuciferine is an ideal functional food for adjuvant lung cancer treatment.
AbstractList Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety and painlessness. Developing new functional food and exploring novel drug targets is important for lung cancer adjuvant therapy. This study confirmed that the active ingredient nuciferine of the lotus leaf was a novel TMEM16A inhibitor by whole-cell patch clamp experiments and site-directed mutagenesis experiments. CCK8 assay, colony formation assay, wound healing assay, and Annexin-V assay were combined to prove that nuciferine inhibited the proliferation and migration of lung cancer cells and promoted cancer cell apoptosis by targeting TMEM16A. Moreover, the combination of nuciferine and cisplatin significantly enhanced the anti-cancer effect of cisplatin. In addition, the signal transduction pathway of nuciferine regulating LA795 cell proliferation, migration, and apoptosis was confirmed by western blot experiments. In vivo experiments showed that nuciferine was a safe and effective natural anti-cancer product for lung cancer. Tissue section pathological detection and pharmacokinetic experiments verified that intragastric administration of nuciferine significantly enhanced the cancer therapy effect of cisplatin and counteracted the toxicity of high concentrations of cisplatin. Therefore, nuciferine is an ideal functional food for adjuvant lung cancer treatment.
Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety and painlessness. Developing new functional food and exploring novel drug targets is important for lung cancer adjuvant therapy. This study confirmed that the active ingredient nuciferine of the lotus leaf was a novel TMEM16A inhibitor by whole-cell patch clamp experiments and site-directed mutagenesis experiments. CCK8 assay, colony formation assay, wound healing assay, and Annexin-V assay were combined to prove that nuciferine inhibited the proliferation and migration of lung cancer cells and promoted cancer cell apoptosis by targeting TMEM16A. Moreover, the combination of nuciferine and cisplatin significantly enhanced the anti-cancer effect of cisplatin. In addition, the signal transduction pathway of nuciferine regulating LA795 cell proliferation, migration, and apoptosis was confirmed by western blot experiments. In vivo experiments showed that nuciferine was a safe and effective natural anti-cancer product for lung cancer. Tissue section pathological detection and pharmacokinetic experiments verified that intragastric administration of nuciferine significantly enhanced the cancer therapy effect of cisplatin and counteracted the toxicity of high concentrations of cisplatin. Therefore, nuciferine is an ideal functional food for adjuvant lung cancer treatment.Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety and painlessness. Developing new functional food and exploring novel drug targets is important for lung cancer adjuvant therapy. This study confirmed that the active ingredient nuciferine of the lotus leaf was a novel TMEM16A inhibitor by whole-cell patch clamp experiments and site-directed mutagenesis experiments. CCK8 assay, colony formation assay, wound healing assay, and Annexin-V assay were combined to prove that nuciferine inhibited the proliferation and migration of lung cancer cells and promoted cancer cell apoptosis by targeting TMEM16A. Moreover, the combination of nuciferine and cisplatin significantly enhanced the anti-cancer effect of cisplatin. In addition, the signal transduction pathway of nuciferine regulating LA795 cell proliferation, migration, and apoptosis was confirmed by western blot experiments. In vivo experiments showed that nuciferine was a safe and effective natural anti-cancer product for lung cancer. Tissue section pathological detection and pharmacokinetic experiments verified that intragastric administration of nuciferine significantly enhanced the cancer therapy effect of cisplatin and counteracted the toxicity of high concentrations of cisplatin. Therefore, nuciferine is an ideal functional food for adjuvant lung cancer treatment.
Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety and painlessness. Developing new functional food and exploring novel drug targets is important for lung cancer adjuvant therapy. This study confirmed that the active ingredient nuciferine of the lotus leaf was a novel TMEM16A inhibitor by whole-cell patch clamp experiments and site-directed mutagenesis experiments. CCK8 assay, colony formation assay, wound healing assay, and Annexin-V assay were combined to prove that nuciferine inhibited the proliferation and migration of lung cancer cells and promoted cancer cell apoptosis by targeting TMEM16A. Moreover, the combination of nuciferine and cisplatin significantly enhanced the anti-cancer effect of cisplatin. In addition, the signal transduction pathway of nuciferine regulating LA795 cell proliferation, migration, and apoptosis was confirmed by western blot experiments. experiments showed that nuciferine was a safe and effective natural anti-cancer product for lung cancer. Tissue section pathological detection and pharmacokinetic experiments verified that intragastric administration of nuciferine significantly enhanced the cancer therapy effect of cisplatin and counteracted the toxicity of high concentrations of cisplatin. Therefore, nuciferine is an ideal functional food for adjuvant lung cancer treatment.
Author Bai, Xue
An, Hailong
Kang, Xianjiang
Guo, Shuai
Li, Shuting
Liu, Xinyi
AuthorAffiliation School of Life Sciences
Key Laboratory of Molecular Biophysics, Institute of Biophysics, School of Sciences
AuthorAffiliation_xml – name: Key Laboratory of Molecular Biophysics, Institute of Biophysics, School of Sciences
– name: School of Life Sciences
Author_xml – sequence: 1
  givenname: Xue
  surname: Bai
  fullname: Bai, Xue
  organization: School of Life Sciences
– sequence: 2
  givenname: Xinyi
  surname: Liu
  fullname: Liu, Xinyi
  organization: School of Life Sciences
– sequence: 3
  givenname: Shuting
  surname: Li
  fullname: Li, Shuting
  organization: School of Life Sciences
– sequence: 4
  givenname: Hailong
  surname: An
  fullname: An, Hailong
  organization: Key Laboratory of Molecular Biophysics, Institute of Biophysics, School of Sciences
– sequence: 5
  givenname: Xianjiang
  surname: Kang
  fullname: Kang, Xianjiang
  organization: School of Life Sciences
– sequence: 6
  givenname: Shuai
  orcidid: 0000-0002-5342-9666
  surname: Guo
  fullname: Guo, Shuai
  email: guoshuai@hbu.edu.cn
  organization: School of Life Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35298888$$D View this record in MEDLINE/PubMed
BookMark eNqNkb1PwzAQxS0Eoh-wMyGPDKT44jp2xqqUUqmFpcyR4zjUVeoUO0Hqf49LCwMSCC8n637vdPdeD53a2mqEroAMgMRwJ5UfrGWpBqCIoJydoC6wmEQMQJyiLglMJFgCHdTzfk0IEYyTc9ShLE5FeF00fWqVKbUzVuOZXZncNB4vF5MFJCNsLL43upFuh0fFun2XtsHLlXZyu8Nl7fC8ta94LK3S7gKdlbLy-vJY--jlYbIcP0bz5-lsPJpHkiasiRSNRcxpQXQaVpY0D_9USkaHJRdCx0oLxUHkrOQF45CwgqoCQMVFDsATTvvo5jB36-q3Vvsm2xivdFVJq-vWZ3EyFIITGIr_oBAsSdkevT6ibb7RRbZ1ZhOuzr58CgA5AMrV3jtdfiNAsn0UWYgi20eRHaMIkuSHRJlGNqa2jZOm-kt4exB-durW2WDo7_gHHUGbtQ
CitedBy_id crossref_primary_10_1016_j_jare_2023_11_003
crossref_primary_10_1016_j_cpan_2025_01_002
crossref_primary_10_1016_j_biopha_2022_113392
crossref_primary_10_1021_acs_jafc_3c06142
crossref_primary_10_1016_j_bmcl_2022_129034
crossref_primary_10_1016_j_ijbiomac_2024_134587
crossref_primary_10_3390_antiox13060714
crossref_primary_10_1038_s41598_024_57595_w
crossref_primary_10_1021_acs_jafc_2c06723
crossref_primary_10_1016_j_intimp_2023_110914
crossref_primary_10_1080_07391102_2023_2272743
crossref_primary_10_1016_j_ijbiomac_2023_125128
crossref_primary_10_1016_j_lfs_2023_122034
crossref_primary_10_48130_MPB_2023_0020
crossref_primary_10_1016_j_jbc_2023_104780
crossref_primary_10_1016_j_phymed_2022_154536
crossref_primary_10_1021_acs_jafc_2c03009
crossref_primary_10_1021_acs_jafc_2c04817
crossref_primary_10_1186_s13046_022_02405_2
crossref_primary_10_1016_j_ijbiomac_2024_134057
crossref_primary_10_3390_ijms241914532
crossref_primary_10_1016_j_ijbiomac_2022_11_123
crossref_primary_10_3389_fphar_2023_1264324
crossref_primary_10_1142_S0192415X22500616
crossref_primary_10_1016_j_ijbiomac_2024_130618
crossref_primary_10_1016_j_prmcm_2022_100167
crossref_primary_10_1021_acs_jafc_4c04929
crossref_primary_10_1186_s12890_024_02860_x
crossref_primary_10_1016_j_phrs_2023_106820
Cites_doi 10.1371/journal.pone.0036197
10.1038/s41571-020-00432-6
10.1111/jipb.12606
10.1016/j.phrs.2020.104721
10.1016/s0140-6736(16)30958-8
10.1016/j.csbj.2020.03.015
10.1016/j.jconrel.2020.11.047
10.3389/fphar.2020.00858
10.1155/2017/1583185
10.3390/ijms222010930
10.3389/fphar.2020.00528
10.1007/s00232-021-00188-9
10.1016/j.cllc.2020.11.005
10.3233/cbm-161507
10.1007/s11655-015-2140-3
10.1001/jamaoncol.2015.2095
10.3389/fphar.2021.643489
10.1016/j.phrs.2019.104323
10.1038/nrclinonc.2017.30
10.1007/s00424-017-1934-x
10.4172/pharmaceutical-sciences.1000277
10.1016/j.bpj.2019.11.015
10.1002/jcp.27865
10.1038/s41572-019-0064-5
10.1002/jcp.27529
10.1007/s00384-020-03711-x
10.1016/j.bcp.2020.114062
10.1007/s10555-018-9744-y
10.2174/1871520620666200403144945
10.1038/nrd.2016.230
10.1002/fsn3.1165
10.1371/journal.pone.0063770
10.1007/s00217-010-1290-y
10.3390/molecules23102723
10.1136/bmj.m4087
10.1016/j.jchromb.2010.04.020
10.1016/j.suronc.2019.04.003
10.1016/j.jbc.2021.101016
10.1007/s00424-020-02434-w
10.1186/s40880-019-0402-8
10.3390/cancers13184499
ContentType Journal Article
Copyright 2022 American Chemical Society
Copyright_xml – notice: 2022 American Chemical Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
DOI 10.1021/acs.jafc.1c08375
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Agriculture
EISSN 1520-5118
EndPage 3696
ExternalDocumentID 35298888
10_1021_acs_jafc_1c08375
h85819233
Genre Journal Article
GroupedDBID -
4.4
55A
5GY
5VS
7~N
85S
AABXI
ABFLS
ABFRP
ABMVS
ABUCX
ACGFS
ACJ
ACS
AEESW
AENEX
AFEFF
AGXLV
AHGAQ
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
CS3
DU5
EBS
ED
F5P
GGK
GNL
GX1
IH9
JG
K2
LG6
P2P
ROL
TWZ
UI2
VF5
VG9
W1F
WH7
X
---
-~X
.K2
AAHBH
AAYXX
ABBLG
ABJNI
ABLBI
ABQRX
ACGFO
ADHLV
BAANH
CITATION
CUPRZ
ED~
JG~
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
ID FETCH-LOGICAL-a365t-c328273d0e91c0a3b3289aa534f788e2ce8c718b5f7d57165d3cd11c2db117673
IEDL.DBID ACS
ISSN 0021-8561
1520-5118
IngestDate Thu Jul 10 18:21:14 EDT 2025
Fri Jul 11 00:10:44 EDT 2025
Thu Jan 02 22:55:30 EST 2025
Tue Jul 01 01:40:08 EDT 2025
Thu Apr 24 22:52:01 EDT 2025
Fri Apr 01 15:02:32 EDT 2022
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords nuciferine
lung cancer
adjuvant therapy
functional food
TMEM16A
Language English
License https://doi.org/10.15223/policy-029
https://doi.org/10.15223/policy-037
https://doi.org/10.15223/policy-045
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a365t-c328273d0e91c0a3b3289aa534f788e2ce8c718b5f7d57165d3cd11c2db117673
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-5342-9666
PMID 35298888
PQID 2641000958
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_2648870148
proquest_miscellaneous_2641000958
pubmed_primary_35298888
crossref_primary_10_1021_acs_jafc_1c08375
crossref_citationtrail_10_1021_acs_jafc_1c08375
acs_journals_10_1021_acs_jafc_1c08375
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-03-30
PublicationDateYYYYMMDD 2022-03-30
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-30
  day: 30
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of agricultural and food chemistry
PublicationTitleAlternate J. Agric. Food Chem
PublicationYear 2022
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref9/cit9
ref6/cit6
ref36/cit36
ref3/cit3
ref27/cit27
ref18/cit18
ref11/cit11
ref25/cit25
ref16/cit16
ref29/cit29
ref32/cit32
ref23/cit23
ref39/cit39
ref14/cit14
ref8/cit8
Huang B. T. (ref22/cit22) 2015; 34
ref5/cit5
ref31/cit31
ref2/cit2
ref34/cit34
ref37/cit37
ref28/cit28
ref40/cit40
ref20/cit20
ref17/cit17
ref10/cit10
ref26/cit26
ref35/cit35
ref19/cit19
ref21/cit21
ref12/cit12
ref15/cit15
ref42/cit42
ref41/cit41
ref13/cit13
ref33/cit33
ref4/cit4
ref30/cit30
ref1/cit1
ref24/cit24
ref38/cit38
ref7/cit7
References_xml – ident: ref11/cit11
  doi: 10.1371/journal.pone.0036197
– ident: ref1/cit1
  doi: 10.1038/s41571-020-00432-6
– ident: ref35/cit35
  doi: 10.1111/jipb.12606
– volume: 34
  start-page: 2084
  year: 2015
  ident: ref22/cit22
  publication-title: Lat. Am. J. Pharm.
– ident: ref37/cit37
  doi: 10.1016/j.phrs.2020.104721
– ident: ref6/cit6
  doi: 10.1016/s0140-6736(16)30958-8
– ident: ref38/cit38
  doi: 10.1016/j.csbj.2020.03.015
– ident: ref13/cit13
  doi: 10.1016/j.jconrel.2020.11.047
– ident: ref21/cit21
  doi: 10.3389/fphar.2020.00858
– ident: ref23/cit23
  doi: 10.1155/2017/1583185
– ident: ref32/cit32
  doi: 10.3390/ijms222010930
– ident: ref42/cit42
  doi: 10.3389/fphar.2020.00528
– ident: ref26/cit26
  doi: 10.1007/s00232-021-00188-9
– ident: ref2/cit2
  doi: 10.1016/j.cllc.2020.11.005
– ident: ref10/cit10
  doi: 10.3233/cbm-161507
– ident: ref41/cit41
  doi: 10.1007/s11655-015-2140-3
– ident: ref9/cit9
  doi: 10.1001/jamaoncol.2015.2095
– ident: ref25/cit25
  doi: 10.3389/fphar.2021.643489
– ident: ref29/cit29
  doi: 10.1016/j.phrs.2019.104323
– ident: ref4/cit4
  doi: 10.1038/nrclinonc.2017.30
– ident: ref27/cit27
  doi: 10.1007/s00424-017-1934-x
– ident: ref17/cit17
  doi: 10.4172/pharmaceutical-sciences.1000277
– ident: ref28/cit28
  doi: 10.1016/j.bpj.2019.11.015
– ident: ref30/cit30
  doi: 10.1002/jcp.27865
– ident: ref7/cit7
  doi: 10.1038/s41572-019-0064-5
– ident: ref36/cit36
  doi: 10.1002/jcp.27529
– ident: ref15/cit15
  doi: 10.1007/s00384-020-03711-x
– ident: ref31/cit31
  doi: 10.1016/j.bcp.2020.114062
– ident: ref16/cit16
  doi: 10.1007/s10555-018-9744-y
– ident: ref5/cit5
  doi: 10.2174/1871520620666200403144945
– ident: ref24/cit24
  doi: 10.1038/nrd.2016.230
– ident: ref34/cit34
  doi: 10.1002/fsn3.1165
– ident: ref19/cit19
  doi: 10.1371/journal.pone.0063770
– ident: ref33/cit33
  doi: 10.1007/s00217-010-1290-y
– ident: ref18/cit18
  doi: 10.3390/molecules23102723
– ident: ref3/cit3
  doi: 10.1136/bmj.m4087
– ident: ref20/cit20
  doi: 10.1016/j.jchromb.2010.04.020
– ident: ref12/cit12
  doi: 10.1016/j.suronc.2019.04.003
– ident: ref39/cit39
  doi: 10.1016/j.jbc.2021.101016
– ident: ref40/cit40
  doi: 10.1007/s00424-020-02434-w
– ident: ref8/cit8
  doi: 10.1186/s40880-019-0402-8
– ident: ref14/cit14
  doi: 10.3390/cancers13184499
SSID ssj0008570
Score 2.5151262
Snippet Lung cancer is a malignant tumor with the highest morbidity and mortality rates. Food therapy is a common adjuvant treatment for lung cancer due to its safety...
SourceID proquest
pubmed
crossref
acs
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3687
SubjectTerms active ingredients
adjuvants
antineoplastic activity
apoptosis
Aporphines - pharmacology
Aporphines - therapeutic use
Bioactive Constituents, Metabolites, and Functions
cancer therapy
Cell Proliferation
cisplatin
food chemistry
functional foods
Humans
intragastric administration
leaves
lung neoplasms
Lung Neoplasms - drug therapy
Lung Neoplasms - genetics
Lung Neoplasms - metabolism
morbidity
mortality
neoplasm cells
pharmacokinetics
Signal Transduction
site-directed mutagenesis
toxicity
Western blotting
Title Nuciferine Inhibits TMEM16A in Dietary Adjuvant Therapy for Lung Cancer
URI http://dx.doi.org/10.1021/acs.jafc.1c08375
https://www.ncbi.nlm.nih.gov/pubmed/35298888
https://www.proquest.com/docview/2641000958
https://www.proquest.com/docview/2648870148
Volume 70
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3JTsMwELVYLnBgX8omI8GBQ0ptx1mOUaEsor3QSr1F3gIFFFCTHODrGSehiK0it0R2EttjzxvPzDNCR56iCciGcWRCueP6LndCJloOTwDOSSaI5jbfudvzLgfu9ZAPP2lyvnvwKTkVKms-iEQ1iQK44PNZNE-9wLeGVtS-nay6lqi9CucgTgCgoHZJ_vYGq4hU9lUR_YEuSy3TWa6OK8pKckIbXPLYLHLZVG8_qRv_0YAVtFSDTRxV0rGKZky6hhaju3FNuGHW0UWvUDa6BcAmvkrvR3KUZ7jfPe8SL8KjFJ-NTC7GrzjSDwWA7hz3KxoCDGAX38BKgdtWbsYbaNA577cvnfpwBUcwj-eOYmBs-Uy3TAj_JZiE-1AIztwErGJDlQkU6C3JE19zMKq4ZkoToqiWhPiezzbRXPqcmm2EQ5eEgtm9EcADigVSGigVMEG1xxLtNtAx9EFcT44sLv3elMTlQ-iYuO6YBjr9GJFY1Qzl9qCMpyk1TiY1Xip2jillDz8GOYYpZP0iIjXPRRYDJiQl1gymloHl2G6_NtBWJSGTLwKGDQO4dv7Zzl20QG0Shc1sbO2huXxcmH2ANrk8KGX6HWFs8GE
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV1Jb9NAFH4q5VB6YC0Q1kFqDxycZmY8Xg4crHRJaJJLU6k3dzZDWuSi2BYq_4a_wi_jje0EgWjUSyV8szUznuXNe9-btwzAdqBZhrRhPZUx4fmhL7yYy54nMoRziktqhIt3Hk-CwYn_8VScrsGPRSwMdqLAloraiP87uwDddd_OZaa7VCNqCBd-lEf26htqacWH4R4u6Q5jB_vT_sBrLxLwJA9E6WmOikXITc_GWFtyhe-xlIL7GWqAlmkbaeTRSmShEahACMO1oVQzoygNg5Bju3fgLmIf5vS7pH-8ZPYuP3zjRUK9CLFIawn9V4-d_NPFn_LvGlBbC7eDB_BzOS21T8tFtypVV3__K2Pkfz1vD-F-C61J0uyFR7Bm88ewmXyat-lF7BM4nFTa-fIgtCbD_PNMzcqCTMf7YxokZJaTvZkt5fyKJOa8QhWjJNMm6QJBaE9GyBdJ3-2S-Rac3MpInsJ6fpnb50Bin8aSu5MgRD-aR0pZLBVxyUzAM-N3YAfnPG1ZQZHWVn5G0_ojLkTaLkQHdheEkOo2H7u7FuTLihrvlzW-NrlIVpR9t6CtFBmGswLJ3F5WRYoImNbIOlpZBoWPO2zuwLOGMJd_RMQeR_i8uOE438LGYDoepaPh5Ogl3GMufMTFdPZewXo5r-xrBHWlelNvKwJnt02PvwAqjlGP
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV1Lb9NAEB6VIiF64E0Jz0WiBw5Os7tePw4crKShoU2ERCr15u7LNC1yotgWKv-Hv8LvYtZ2IoEg4lIJ32ztrvcxM_vNzmMB3gSaZUgb1lMZE54f-sKLuex5IkM4p7ikRrh45_EkODzxP5yK0y34voqFwU4U2FJRG_EdVy9M1mYYoPvu-4XMdJdqRA7hypfyyF59RU2teDca4LLuMTY8mPYPvfYyAU_yQJSe5qhchNz0bIy1JVf4HkspuJ-hFmiZtpFGOa1EFhqBSoQwXBtKNTOK0jAIObZ7A246K6HT8ZL-p7XAdzniG08S6kWIR1pr6J967PZAXfy6B_4F2NYb3PAu_FhPTe3XctmtStXV337LGvnfz909uNNCbJI0PHEftmz-AHaSz8s2zYh9CO8nlXY-PQixySg_n6lZWZDp-GBMg4TMcjKY2VIur0hiLipUNUoybZIvEIT45BjlI-k7blk-gpNrGclj2M7nuX0CJPZpLLk7EUIUpHmklMVSEZfMBDwzfgf2cM7TViQUaW3tZzStP-JCpO1CdGB_RQypbvOyu-tBvmyo8XZdY9HkJNlQ9vWKvlIUHM4aJHM7r4oUkTCtEXa0sQxuQu7QuQO7DXGu_4jIPY7wefqP43wFtz4OhunxaHL0DG4zF0XiQjt7z2G7XFb2BWK7Ur2sOYvA2XWT4093zlQS
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nuciferine+Inhibits+TMEM16A+in+Dietary+Adjuvant+Therapy+for+Lung+Cancer&rft.jtitle=Journal+of+agricultural+and+food+chemistry&rft.au=Bai%2C+Xue&rft.au=Liu%2C+Xinyi&rft.au=Li%2C+Shuting&rft.au=An%2C+Hailong&rft.date=2022-03-30&rft.issn=1520-5118&rft.volume=70&rft.issue=12+p.3687-3696&rft.spage=3687&rft.epage=3696&rft_id=info:doi/10.1021%2Facs.jafc.1c08375&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-8561&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-8561&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-8561&client=summon